# EDGAR Filing Document

**Accession Number:** 0001632901
**File Stem:** 0001632901-25-000004
**Filing Date:** 2025-10
**Character Count:** 8517
**Document Hash:** 1520379ca768e1321c4ead69ade38751
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001632901-25-000004.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001632901-25-000004

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251028

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Curet Myriam
- **CENTRAL INDEX KEY:** 0001632901

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-30713
- **FILM NUMBER:** 251431681

**BUSINESS ADDRESS:**
- **STREET 1:** 1020 KIFER ROAD
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94086
- **BUSINESS PHONE:** 408-523-7587

**MAIL ADDRESS:**
- **STREET 1:** 1020 KIFER ROAD
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94086

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Myriam Curet
- **DATE OF NAME CHANGE:** 20150205
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTUITIVE SURGICAL INC
- **CENTRAL INDEX KEY:** 0001035267
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 770416458
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1020 KIFER ROAD
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94086
- **BUSINESS PHONE:** 4085232100

**MAIL ADDRESS:**
- **STREET 1:** 1020 KIFER ROAD
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94086

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Curet Myriam<br><sub>(Last) (First) (Middle)</sub><br>1020 KIFER ROAD<br><sub>(Street)</sub><br>SUNNYVALE, CA 94086<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP & Chief Medical Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>INTUITIVE SURGICAL INC [ ISRG ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-10-28 |  | M<sup>(1)</sup> |  | 5030 | A | $242.3367 | 5383 | D |  |
| Common Stock | 2025-10-28 |  | S<sup>(1)</sup> |  | 5030 | D | 548.4254<sup>(2)</sup> | 353 | D |  |
| Common Stock | 2025-10-28 |  | M<sup>(1)</sup> |  | 1153 | A | $229.39 | 1506 | D |  |
| Common Stock | 2025-10-28 |  | S<sup>(1)</sup> |  | 1153 | D | 548.4254<sup>(2)</sup> | 353 | D |  |
| Common Stock | 2025-10-28 |  | M<sup>(1)</sup> |  | 1379 | A | $208.9 | 1732 | D |  |
| Common Stock | 2025-10-28 |  | S<sup>(1)</sup> |  | 1379 | D | 548.4254<sup>(2)</sup> | 353 | D |  |
| Common Stock | 2025-10-29 |  | M<sup>(1)</sup> |  | 125 | A | $208.9 | 125 | D |  |
| Common Stock | 2025-10-29 |  | S<sup>(1)</sup> |  | 125 | D | $543.0 | 0 | D |  |
| Common Stock |  |  |  |  |  |  |  | 353 | I | by Trust |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Non-Qualified Stock Option (right to buy) | $208.9 | 2025-10-28 |  | M<sup>(1)</sup> |  |  | 1379 | <sup>(3)</sup> | 2029-08-28 | Common Stock | 1379 | $0.0 | 626 | D |  |
| Non-Qualified Stock Option (right to buy) | $208.9 | 2025-10-29 |  | M<sup>(1)</sup> |  |  | 125 | <sup>(3)</sup> | 2029-08-28 | Common Stock | 125 | $0.0 | 501 | D |  |
| Non-Qualified Stock Option (right to buy) | $229.39 | 2025-10-28 |  | M<sup>(1)</sup> |  |  | 1153 | <sup>(4)</sup> | 2030-02-27 | Common Stock | 1153 | $0.0 | 1676 | D |  |
| Non-Qualified Stock Option (right to buy) | $242.3367 | 2025-10-28 |  | M<sup>(1)</sup> |  |  | 5030 | <sup>(3)</sup> | 2030-08-28 | Common Stock | 5030 | $0.0 | 0 | D |  |

---

### Footnotes:

(1) The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

(2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04;  5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

(3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan.  Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

(4) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

**Signature:** By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet  
**Date:** 2025-10-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**